NasdaqCM - Nasdaq Real Time Price USD

Avid Bioservices, Inc. (CDMO)

Compare

12.48

+0.02

+(0.16%)

At close: January 31 at 4:00:02 PM EST

12.48

0.00

(0.00%)

After hours: January 31 at 6:07:50 PM EST

Avid Stockholders Approve Transaction with GHO and Ampersand

TUSTIN, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that Avid stockholders voted to approve the transaction with GHO Capital Partners LLP ("GHO") and Ampersand Capital Partners (“Ampersand”) at

GlobeNewswire yesterday

CDMO
+0.16%
Avid Reminds Stockholders to Vote Today FOR the Transaction with GHO and Ampersand

Mails Letter to Stockholders Highlighting the Significant, Immediate and Certain Cash Value the Transaction Delivers to StockholdersTUSTIN, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that it h

GlobeNewswire 9 days ago

CDMO
+0.16%
Avid Bioservices (CDMO) Started a Sale Process

Laughing Water Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the fourth quarter, Class A interests in Laughing Water Capital returned about 18.6% bringing year-to-date returns to approximately 39.5%. The SP500TR and R2000 returned 2.4% and 0.3% in the quarter and 25% […]

Insider Monkey 9 days ago

CDMO
+0.16%
Avid Recommends Stockholders Follow Recommendations of ISS and Glass Lewis and vote FOR the Transaction with GHO and Ampersand

Leading Independent Proxy Advisory Firms Recognize the Significant, Immediate and Certain Cash Value the Transaction Delivers to Avid StockholdersTUSTIN, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today annou

GlobeNewswire 10 days ago

CDMO
+0.16%
Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand

Avid Urges Stockholders to Vote FOR the Pending Transaction TODAYTUSTIN, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today posted an investor presentation in connection with its pending transaction with GHO Ca

GlobeNewswire 23 days ago

CDMO
+0.16%
Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand

TUSTIN, Calif., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the expiration of the waiting period under the Hart-Scott-Rodino (“HSR”) Antitrust Improvements Act of 1976 with respect to the previously an

GlobeNewswire last month

CDMO
+0.16%
Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction

Files Definitive Proxy Statement and Mails Letter to StockholdersTUSTIN, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that it has commenced mailing definitive proxy materials and a letter to sto

GlobeNewswire last month

CDMO
+0.16%
Avid Bioservices: Fiscal Q2 Earnings Snapshot

TUSTIN, Calif. AP) — Avid Bioservices Inc. CDMO) on Tuesday reported a loss of $17.4 million in its fiscal second quarter.

Associated Press Finance last month

CDMO
+0.16%
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024

TUSTIN, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced financial results for the second quarter and six months ended October 31, 2024. Highlights from the Quarter Ended October 31, 2024: “We delivered solid results in a comp

GlobeNewswire last month

CDMO
+0.16%
Avid Bioservices, Inc. (CDMO): A Bull Case Theory

We came across a bullish thesis on Avid Bioservices, Inc. (CDMO) on Twitter by northeasternsvf. In this article, we will summarize the bulls’ thesis on CDMO. Avid Bioservices, Inc. (CDMO)’s share was trading at $12.20 as of Nov 13th. CDMO’s trailing and forward P/E were 9.41 and 88.50 respectively according to Yahoo Finance. Avid Bioservices, Inc., a […]

Insider Monkey 2 months ago

CDMO
+0.16%
CTLT
Avid Bioservices to be Acquired in $1.1 Billion Deal

Avid Bioservices ( (CDMO) ) just unveiled an announcement. Avid Bioservices, a biologics contract development and manufacturing organization, is set to be acquired by GHO Capital Partners and Ampersand Capital Partners in a $1.1 billion all-cash transaction. Shareholders will receive $12.50 per share, representing a premium to recent trading prices. The merger is expected to close in early 2025, subject to customary conditions and approvals. This acquisition aims to leverage the expertise and ca

TipRanks 2 months ago

CDMO
+0.16%
GHO and Ampersand Capital to acquire Avid Bioservices

The definitive merger agreement stipulates that GHO and Ampersand will purchase all outstanding shares of Avid.

Pharmaceutical Technology 2 months ago

CDMO
+0.16%
Avid Bioservices to Go Private in $1.1 Billion Deal

Avid Bioservices Chief Executive Nick Green said the company’s board considered several options before determining to move forward as a private company under new owners.

The Wall Street Journal 2 months ago

CDMO
+0.16%
Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction

TUSTIN, Calif. and LONDON and BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, GHO Capital Partners LLP ("GHO") and Ampersand Capital Partners (“Ampersand”) today announced they have entered into a definitive merge

GlobeNewswire 2 months ago

CDMO
+0.16%
State Street Corp's Strategic Reduction in Avid Bioservices Inc Holdings

On September 30, 2024, State Street Corp executed a significant transaction involving the shares of Avid Bioservices Inc (NASDAQ:CDMO), a key player in the biopharmaceutical sector. State Street Corp, headquartered at One Lincoln Street, Boston, MA, is a prominent financial services provider known for its robust investment strategies. The firm manages a diverse portfolio with a strong emphasis on technology and financial services, holding significant positions in major companies like Apple Inc (NASDAQ:AAPL) and Amazon.com Inc (NASDAQ:AMZN).

GuruFocus.com 3 months ago

CDMO
+0.16%
STT
Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference

TUSTIN, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate in the upcoming Craig-Hallum Bioprocessing Conference. Nick Green, president and chief executive officer, and Pramthesh Patel, Ph.D.,

GlobeNewswire 4 months ago

CDMO
+0.16%
Avid Bioservices First Quarter 2025 Earnings: Misses Expectations

Avid Bioservices ( NASDAQ:CDMO ) First Quarter 2025 Results Key Financial Results Revenue: US$40.2m (up 6.5% from 1Q...

Simply Wall St. 4 months ago

CDMO
+0.16%
Q1 2025 Avid Bioservices Inc Earnings Call

Q1 2025 Avid Bioservices Inc Earnings Call

Thomson Reuters StreetEvents 4 months ago

CDMO
+0.16%
HALO
Avid Bioservices: Fiscal Q1 Earnings Snapshot

CDMO) on Monday reported a loss of $5.5 million in its fiscal first quarter. The Tustin, California-based company said it had a loss of 9 cents per share. Losses, adjusted for stock option expense and non-recurring costs, came to 3 cents per share.

Associated Press Finance 4 months ago

CDMO
+0.16%
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024

-- Recorded First Quarter Revenue of $40.2 Million -- -- Signed $66 Million in Net New Business, Resulting in Backlog of $219 Million -- -- Maintained FY2025 Revenue Guidance of Between $160 Million and $168 Million -- TUSTIN, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechno

GlobeNewswire 4 months ago

CDMO
+0.16%

Performance Overview

Return	CDMO	S&P 500
YTD	+1.22%	+2.26%
1-Year	+80.61%	+22.65%
3-Year	-28.40%	+36.30%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Avid Bioservices, Inc. (CDMO)

Avid Stockholders Approve Transaction with GHO and Ampersand

Avid Reminds Stockholders to Vote Today FOR the Transaction with GHO and Ampersand

Avid Bioservices (CDMO) Started a Sale Process

Avid Recommends Stockholders Follow Recommendations of ISS and Glass Lewis and vote FOR the Transaction with GHO and Ampersand

Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand

Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand

Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction

Avid Bioservices: Fiscal Q2 Earnings Snapshot

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024

Avid Bioservices, Inc. (CDMO): A Bull Case Theory

Avid Bioservices to be Acquired in $1.1 Billion Deal

GHO and Ampersand Capital to acquire Avid Bioservices

Avid Bioservices to Go Private in $1.1 Billion Deal

Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction

State Street Corp's Strategic Reduction in Avid Bioservices Inc Holdings

Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference

Avid Bioservices First Quarter 2025 Earnings: Misses Expectations

Q1 2025 Avid Bioservices Inc Earnings Call

Avid Bioservices: Fiscal Q1 Earnings Snapshot

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024

Performance Overview